Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Human Disease Phenotypes Associated with Loss and Gain of Function Mutations in STAT2: Viral Susceptibility and Type I Interferonopathy

Lookup NU author(s): Professor Christopher DuncanORCiD, Professor Sophie HambletonORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

STAT2 is distinguished from other STAT family members by its exclusive involvement in type I and III interferon (IFN-I/III) signaling pathways, and its unique behavior as both positive and negative regulator of IFN-I signaling. The clinical relevance of these opposing STAT2 functions is exemplified by monogenic diseases of STAT2. Autosomal recessive STAT2 deficiency results in heightened susceptibility to severe and/or recurrent viral disease, whereas homozygous missense substitution of the STAT2-R148 residue is associated with severe type I interferonopathy due to loss of STAT2 negative regulation. Here we review the clinical presentation, pathogenesis, and management of these disorders of STAT2.

Publication metadata

Author(s): Duncan CJA, Hambleton S

Publication type: Review

Publication status: Published

Journal: Journal of Clinical Immunology

Year: 2021

Volume: 41

Issue: 7

Pages: 1446-1456

Print publication date: 06/10/2021

Online publication date: 26/08/2021

Acceptance date: 03/08/2021

ISSN (print): 0271-9142

ISSN (electronic): 1573-2592

URL: https://doi.org/10.1007/s10875-021-01118-z

DOI: 10.1007/s10875-021-01118-z

PubMed id: 34448086

Share